Shareholders of healthcare-at-home specialist Amedisys voted in favor of the roughly $3.3 billion pending acquisition by Optum, a subsidiary of UnitedHealth Group, in accordance with a Securities and Trade Fee submitting.
The shareholders authorised the adoption of the merger settlement, in addition to compensation to the corporate’s govt officers in reference to the merger.
Nonetheless, the deal continues to be below assessment by the Division of Justice.
Amedisys filed notifications of the merger with the Federal Commerce Fee and Antitrust Division of the Division of Justice in July, and in an SEC submitting final month mentioned it acquired a request for extra info from the DOJ, extending the HSR Act ready interval till the events have fulfilled the DOJ’s calls for.
Although shareholders have authorised the deal, its finalization is topic to approval from sure state regulatory and authorities authorities.
THE LARGER TREND
In June, UnitedHealth Group introduced its plans to buy the Louisiana-based house healthcare supplier in an all-cash deal, beating out Possibility Care Well being.
In line with a Could SEC submitting, Possibility Care Well being entered into an Settlement and Plan of Merger with the house well being firm in an all-stock provide, however only one month later entered right into a termination settlement that included a termination price of $106 million payable inside 24 hours of the execution of the settlement.
In February, United Healthcare finalized its acquisition of one other house well being firm, LHC Group, in a $5.4 billion deal, additional increasing its attain within the house healthcare market.